Pharmacokinetics in Adolescents - PEAK
Study identifier:D9830C00021
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
An open, single centre, phase I study in male adolescents with asthma, aged 12 to 17 years, to assess pharmacokinetics of orally administered AZD1981 tablets 100 mg twice daily for 61/2 days
Medical condition
asthma
Phase
Phase 1
Healthy volunteers
No
Study drug
AZD1981 100 mg twice daily for 61/2 days
Sex
Male
Actual Enrollment
21
Study type
Interventional
Age
12 Years - 17 Years
Date
Study Start Date: 01 Oct 2010
Primary Completion Date: 01 Feb 2011
Study Completion Date: 01 Feb 2011
Study design
Allocation: N/A
Endpoint Classification: Pharmacokinetics Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Basic Science
Verification:
Verified 01 Nov 2013 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| Experimental: 1 AZD1981 100 mg twice daily for 6 ½ days | Drug: AZD1981 100 mg twice daily for 61/2 days 100 mg tablets |
Contacts
Investigators
Principal Investigator
Christer Hultquist
AstraZeneca
